Flex Capital is excited to announce our investment in Kin Health's $9M seed round.
The most important moment in a patient's care is the conversation with their doctor — yet patients walk out of roughly one billion appointments a year in the US without a reliable record of what was actually said. Kin Health is building the tool to change that, and at Flex we're thrilled to be part of the mission.
Flex Capital is proud to participate in Kin Health's $9 million seed round led by Maveron, alongside Town Hall Ventures, Eniac Ventures, Pear VC, Foundry Square Capital, The Family Fund, and Watershed Ventures. The round also drew an exceptional group of operators, including GoodRx co-founders Doug Hirsch and Trevor Bezdek — now Kin's founding partners and executive chairmen — and more than 30 physicians.
What Kin Does
- A clear record of every visit. Kin's free, AI-powered notetaker captures the physician-patient conversation and turns it into an easy-to-read summary of what happened and what to do next
- Translating care into plain language. Medications, instructions, and follow-ups are often explained quickly and forgotten within minutes — patients accurately recall only about half of the decisions from a visit. Kin arms patients and caregivers with clarity instead of confusion (BusinessWire).
- A longitudinal health record patients own. Grounded in what doctors actually said, Kin's record is shareable with caregivers and loved ones, helping patients understand their care, follow through, and stay in control (Kin Health).
Why we invested in Kin
Kin is tackling the most universal friction point in healthcare — and doing it from the consumer's side. Following the playbook Doug Hirsch and Trevor Bezdek proved at GoodRx, Kin is free for patients forever, earning revenue from the referrals, labs, and prescriptions that naturally follow an appointment rather than from patients themselves.
Most of all, we invested in the team. Our GP Paul Johnson (former founder/CEO @Lemonaid) - knew Kin's people long before the round came together:
“Kyle Alwyn was one of the best engineers at Lemonaid. When I got the call that he was starting a company, I knew it would be special.”
“Then Rajal and I got to know Arpan Parikh, MD, MBA, FAPA and Amit Parikh MD and heard the vision for Kin: putting patients in the driver's seat of their own care. It's a mission I've been close to for years, and getting involved was a no-brainer.”
— Paul Johnson, General Partner at Flex Capital · Read the full comment on LinkedIn →
We're proud to back the Kin team as they make that real.
